Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
1	1 Sensei Biotherapeutics SNSE $165M	1,223% upside 3 price targets	0
2	2 Unicycive Therapeutics UNCY $82.8M	992% upside 3 price targets	0
3	3 Zura Bio ZURA $70.5M	887% upside 4 price targets	0
4	4 4D Molecular Therapeutics FDMT $192M	759% upside 3 price targets	0
5	5 NRX Pharmaceuticals NRXP $57.7M	753% upside 4 price targets	0
6	6 Cabaletta Bio CABA $167M	751% upside 6 price targets	0
7	7 Compass Therapeutics CMPX $303M	722% upside 4 price targets	0
8	8 Metagenomi MGX $54.6M	699% upside 3 price targets	0
9	9 Immuneering IMRX $65.5M	688% upside 3 price targets	0
10	10 Aclaris Therapeutics ACRS $152M	686% upside 3 price targets	0
11	11 Nkarta NKTX $128M	673% upside 4 price targets	0
12	12 Atossa Therapeutics ATOS $105M	661% upside 3 price targets	0
13	13 Elevation Oncology ELEV $22.6M	637% upside 5 price targets	0
14	IRD 14 Opus Genetics, Inc. Common Stock IRD $55.1M	631% upside 4 price targets	0
15	15 Esperion Therapeutics ESPR $216M	603% upside 3 price targets	0
16	16 Clene CLNN $38M	591% upside 4 price targets	0
17	17 SAB Biotherapeutics SABS $16.5M	574% upside 3 price targets	0
18	18 Karyopharm Therapeutics KPTI $37.8M	548% upside 3 price targets	0
19	19 Larimar Therapeutics LRMR $172M	544% upside 3 price targets	0
20	20 Astria Therapeutics ATXS $322M	543% upside 3 price targets	0
21	SLN 21 Silence Therapeutics SLN $254M	542% upside 4 price targets	0
22	22 Allogene Therapeutics ALLO $284M	526% upside 7 price targets	0
23	23 Corbus Pharmaceuticals CRBP $101M	520% upside 3 price targets	0
24	24 Humacyte HUMA $361M	515% upside 3 price targets	0
25	25 Olema Pharmaceuticals OLMA $274M	511% upside 4 price targets	0

12345

65